about kinex

Kinex Pharmaceuticals - Buffalo NY Biotechnology Company

Kinex is a specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases.

Our Company >>

clinical trials

Kinex Pharmaceuticals Clinical Trials

Kinex has numerous clinical oncology studies underway or in the planning stage.

Clinical Trials >>

News/Events

Kinex Pharmaceuticals Appoints Chief Operating Officer Wednesday, December 17th, 2014

Kinex Pharmaceuticals announced today that Mr. Flint Besecker has been appointed Chief Operating Officer of the company. Mr. Besecker will have additional

Hanmi Pharmaceuticals and Collaborative Partner Kinex Pharmaceuticals Announce Preliminary Results from a Phase I Clinical Study (HM-OTE-103) with Oratecan® in Patients with Advanced Cancer Wednesday, October 15th, 2014

Hanmi Pharmaceuticals and Collaborative Partner Kinex Pharmaceuticals announce today preliminary results from a Phase I Clinical Study of Oratecan – an oral

News/Events >>